Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Kabiven

Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids

Terminated Labeling / mix-up Fresenius Kabi USA, LLC D-1114-2015
Class I · High risk

Adrucil (fluorouracil injection, USP)

Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA NDC 0703-3019-11 D-1089-2015
Class II · Moderate risk

Alinia (nitazoxanide)

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Terminated Stability / shelf life Romark Laboratories, L.C. D-0983-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1415-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1414-2015
Class II · Moderate risk

Estradiol cream

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1413-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1412-2015
Class II · Moderate risk

Estriol

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1411-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1410-2015
Class II · Moderate risk

Estradiol

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1409-2015
Class II · Moderate risk

Estradiol

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1408-2015
Class II · Moderate risk

Tri-Est 80:10:10 Progesterone

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1407-2015
Class II · Moderate risk

Meloxicam capsules

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1339-2015
Class II · Moderate risk

Leucovorin Calcium capsules

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1338-2015
Class II · Moderate risk

Bi-Est 80:20 Progesterone

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1337-2015
Class II · Moderate risk

Captopril Tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1277-2015
Class II · Moderate risk

Captopril Tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1276-2015
Class II · Moderate risk

Captopril Tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1275-2015

Recalls by year